These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 17385013

  • 21. The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
    Deng G, Ashley AJ, Brown WE, Eaton JW, Hauck WW, Kikwai LC, Liddell MR, Manning RG, Munoz JM, Nithyanandan P, Glasgow MJ, Stippler E, Wahab SZ, Williams RL.
    Pharm Res; 2008 May; 25(5):1100-9. PubMed ID: 18172581
    [Abstract] [Full Text] [Related]

  • 22. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
    Garbacz G, Wedemeyer RS, Nagel S, Giessmann T, Mönnikes H, Wilson CG, Siegmund W, Weitschies W.
    Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568
    [Abstract] [Full Text] [Related]

  • 23. [In vitro studies of drug liberation from suppositories with the rotating flask method].
    Koch HP, Klissenbauer C, Ritzinger A, Wallentin A.
    Pharmazie; 1987 Mar; 42(3):169-72. PubMed ID: 3602072
    [Abstract] [Full Text] [Related]

  • 24. [Validation of dissolution testing: evaluation of vibration levels of dissolution apparatuses].
    Kaniwa N, Katori N, Aoyagi N, Kojima S, Ishigame N, Seta Y, Shinba T, Fujiwara K, Nakai T, Oda Y.
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998 Mar; (116):189-91. PubMed ID: 10097538
    [Abstract] [Full Text] [Related]

  • 25. Applications of Clinically Relevant Dissolution Testing: Workshop Summary Report.
    Suarez-Sharp S, Cohen M, Kesisoglou F, Abend A, Marroum P, Delvadia P, Kotzagiorgis E, Li M, Nordmark A, Bandi N, Sjögren E, Babiskin A, Heimbach T, Kijima S, Mandula H, Raines K, Seo P, Zhang X.
    AAPS J; 2018 Aug 27; 20(6):93. PubMed ID: 30151612
    [Abstract] [Full Text] [Related]

  • 26. Critical factors in manufacturing multi-layer tablets--assessing material attributes, in-process controls, manufacturing process and product performance.
    Vaithiyalingam SR, Sayeed VA.
    Int J Pharm; 2010 Oct 15; 398(1-2):9-13. PubMed ID: 20656000
    [Abstract] [Full Text] [Related]

  • 27. A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid dosage forms.
    Wang Y, Armenante PM.
    J Pharm Sci; 2012 Feb 15; 101(2):746-60. PubMed ID: 22083630
    [Abstract] [Full Text] [Related]

  • 28. A mini review of scientific and pharmacopeial requirements for the disintegration test.
    Donauer N, Löbenberg R.
    Int J Pharm; 2007 Dec 10; 345(1-2):2-8. PubMed ID: 17935916
    [Abstract] [Full Text] [Related]

  • 29. Dissolution and Translational Modeling Strategies Enabling Patient-Centric Drug Product Development: the M-CERSI Workshop Summary Report.
    Abend A, Heimbach T, Cohen M, Kesisoglou F, Pepin X, Suarez-Sharp S.
    AAPS J; 2018 Apr 09; 20(3):60. PubMed ID: 29633092
    [Abstract] [Full Text] [Related]

  • 30. Regulatory aspects of drug dissolution from a European perspective.
    Graffner C.
    Eur J Pharm Sci; 2006 Nov 09; 29(3-4):288-93. PubMed ID: 16950606
    [Abstract] [Full Text] [Related]

  • 31. The manufacture and characterisation of hot-melt extruded enteric tablets.
    Andrews GP, Jones DS, Diak OA, McCoy CP, Watts AB, McGinity JW.
    Eur J Pharm Biopharm; 2008 May 09; 69(1):264-73. PubMed ID: 18164604
    [Abstract] [Full Text] [Related]

  • 32. Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses.
    Garbacz G, Golke B, Wedemeyer RS, Axell M, Söderlind E, Abrahamsson B, Weitschies W.
    Eur J Pharm Sci; 2009 Sep 10; 38(2):147-55. PubMed ID: 19591927
    [Abstract] [Full Text] [Related]

  • 33. [The importance of micronization in the design of dosage forms I. Theoretical and biopharmaceutical aspects].
    Antal I.
    Acta Pharm Hung; 2006 Sep 10; 76(2):95-103. PubMed ID: 17094668
    [Abstract] [Full Text] [Related]

  • 34. Chemometrics-based process analytical technology (PAT) tools: applications and adaptation in pharmaceutical and biopharmaceutical industries.
    Challa S, Potumarthi R.
    Appl Biochem Biotechnol; 2013 Jan 10; 169(1):66-76. PubMed ID: 23138336
    [Abstract] [Full Text] [Related]

  • 35. A quality by design study applied to an industrial pharmaceutical fluid bed granulation.
    Lourenço V, Lochmann D, Reich G, Menezes JC, Herdling T, Schewitz J.
    Eur J Pharm Biopharm; 2012 Jun 10; 81(2):438-47. PubMed ID: 22446063
    [Abstract] [Full Text] [Related]

  • 36. Roadmap for implementation of quality by design (QbD) for biotechnology products.
    Rathore AS.
    Trends Biotechnol; 2009 Sep 10; 27(9):546-53. PubMed ID: 19647883
    [Abstract] [Full Text] [Related]

  • 37. Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.
    Abdullah MD, Bepary S, Rouf AS.
    Pak J Pharm Sci; 2008 Jan 10; 21(1):70-7. PubMed ID: 18166523
    [Abstract] [Full Text] [Related]

  • 38. Estimation of the probability of passing the USP dissolution test.
    Wang H.
    J Biopharm Stat; 2007 Jan 10; 17(3):407-13. PubMed ID: 17479390
    [Abstract] [Full Text] [Related]

  • 39. [Drug liberation from floating capsules in the rotating-flask solubility tester].
    Koch HP, Mertz M, Zinterhof G.
    Pharmazie; 1987 May 10; 42(5):312-5. PubMed ID: 3671440
    [Abstract] [Full Text] [Related]

  • 40. Dissolution of prednisone tablets in the presence of an arch-shaped fiber optic probe in a USP dissolution testing apparatus 2.
    Zhang Y, Bredael G, Armenante PM.
    J Pharm Sci; 2013 Aug 10; 102(8):2718-29. PubMed ID: 23861178
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.